GSK3888130
/ GSK
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 13, 2024
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants
(clinicaltrials.gov)
- P1 | N=54 | Completed | Sponsor: GlaxoSmithKline | Recruiting ➔ Completed | Trial completion date: Jun 2023 ➔ Oct 2023 | Trial primary completion date: Jun 2023 ➔ Oct 2023
Trial completion • Trial completion date • Trial primary completion date • CNS Disorders • Multiple Sclerosis
1 to 1
Of
1
Go to page
1